Venker Eric Insider Trades

Insider Trading History

Track insider trading activity for Venker Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $52M 1,813,063 shares
Last Trade
May 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.99M 200,000 shares
$29.96
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $128M 4,444,834 shares
Last Trade
May 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.99M 200,000 shares
$29.96
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $46.3M 1,613,063 shares
Last Trade
May 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.05M 200,000 shares
$30.27
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $46.3M 1,613,063 shares
Last Trade
May 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.12M 34,483 shares
$32.41
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $47.3M 1,647,546 shares
Last Trade
Apr 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.92M 200,000 shares
$29.59
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $53M 1,847,546 shares
Last Trade
Apr 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.82M 200,000 shares
$29.08
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $133M 4,644,834 shares
Last Trade
Apr 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.82M 200,000 shares
$29.08
$28.70
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $10.5M 336,043 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14M 568,295 shares
$24.61
$31.15
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $653k 20,970 shares
Last Trade
Apr 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$343k 14,229 shares
$24.10
$31.15
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $34.5M 1,106,250 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.26M 368,750 shares
$25.10
$31.15
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $11.5M 368,750 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.26M 368,750 shares
$25.10
$31.15
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $1.05M 33,790 shares
Last Trade
Apr 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.41M 334,960 shares
$25.10
$31.15
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $47.3M 1,647,546 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.65M 200,000 shares
$28.24
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $139M 4,844,834 shares
Last Trade
Mar 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.66M 200,000 shares
$28.30
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $53M 1,847,546 shares
Last Trade
Mar 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.66M 200,000 shares
$28.30
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $47.3M 1,647,546 shares
Last Trade
Feb 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$191k 7,051 shares
$27.15
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $145M 5,044,834 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.29M 200,000 shares
$26.45
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $47.5M 1,654,597 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.3M 200,000 shares
$26.49
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $53.2M 1,854,597 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.29M 200,000 shares
$26.45
$28.70
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $47.5M 1,654,597 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.38M 200,000 shares
$21.92
$28.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up